Assays of Anti-obesity Activity

Living reference work entry

Abstract

Food intake is measured in acute experiments in normal or obese rats. Additionally, in subchronic or chronic experiments, body weight gain is recorded.

Keywords

Brown Adipose Tissue White Adipose Tissue Indirect Calorimetry Uncouple Protein Brown Adipocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

Food Consumption in Mice and Rats

  1. Abadie JM, Wright B, Correa G, Browne ES, Porter JR, Svec F (1993) Effect of dihydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. Diabetes 42:662–669PubMedGoogle Scholar
  2. Anelli M, Bizzi A, Caccia S, Codegoni AM, Fracasso C, Garattini S (1992) Anorectic activity of fluoxetine and norfluoxetine in mice, rats, and guinea pigs. J Pharm Pharmacol 44:696–698PubMedGoogle Scholar
  3. Antelman SM, Szechtman H (1975) Tail pinch induces eating in sated rats which appears to depend on nigrostriatal dopamine. Science 189:731–733PubMedGoogle Scholar
  4. Bauhofer A, Witte K, Lemmer B, Middeke M, Lorenz W, Celik I (2002) Quality of life in animals as a new outcome for surgical research: G-CSF as a quality of life improving factor. Eur Surg Res 34:22–29PubMedGoogle Scholar
  5. Bickel M, Gossel M, Geisen K, Jaehne G, Lang HJ, Rosenburg R, Sandow J (2004) Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats. Int J Obes 28:211–221Google Scholar
  6. Blavet N, DeFeudis FV, Clostre F (1982) Studies on food intake in the fasted rat. Gen Pharmacol 13:293–297PubMedGoogle Scholar
  7. Bowden CR, Karkanias CD, Bean AJ (1988) Re-evaluation of histidyl-proline diketopiperazine [cyclo(his-pro)] effects on food intake in the rat. Pharmacol Biochem Behav 29:357–363PubMedGoogle Scholar
  8. Caccia S, Anelli M, Fracasso C, Frittoli E, Giorcelli P, Gobbi M, Taddei C, Garattini S, Mennini T (1993) Anorectic effect and brain concentrations of D-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms. Naunyn Schmiedeberg’s Arch Pharmacol 347:306–312Google Scholar
  9. Clark JM, Clark AJM, Winn P (1992) N-methyl-D-aspartate lesions of the lateral hypothalamus do not reduce amphetamine or fenfluramine anorexia but enhance the acquisition of eating in response to tail pinch in the rat. Psychopharmacology (Berl) 109:331–337Google Scholar
  10. Cooper SJ, Dourish CT, Barber DJ (1990a) Fluoxetine reduces food intake by a cholecystokinin-independent mechanism. Pharmacol Biochem Behav 35:51–54PubMedGoogle Scholar
  11. Cooper SJ, Dourish CT, Barber DJ (1990b) Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br J Pharmacol 99:65–70PubMedCentralPubMedGoogle Scholar
  12. Cooper SJ, Francis J, Rusk IN (1990c) The anorectic effect of SK&F 38393, a selective dopamine D1 agonist: a microstructural analysis of feeding and related behavior. Psychopharmacology (Berl) 100:182–187Google Scholar
  13. Cooper SJ, Francis J, Barber DJ (1993) Selective dopamine D-1 receptor antagonists, SK&F 38393 and CY 208–243 reduce sucrose sham-feeding in the rat. Neuropharmacol 32:101–102Google Scholar
  14. Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 86:197–204Google Scholar
  15. Dourish CT, Hutson PH, Curzon G (1986) Para-chlorophenyl-alanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology (Berl) 89:467–471Google Scholar
  16. Eberle-Wang K, Simansky KJ (1992) The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats. Pharmacol Biochem Behav 43:943–947PubMedGoogle Scholar
  17. Fantino M, Cabanac M (1980) Body weight regulation with a proportional hoarding response. Physiol Behav 24:939–942PubMedGoogle Scholar
  18. Fantino M, Faïon F, Roland Y (1986) Effect of dexfenfluramine on body weight set-point: study in the rat with hoarding behavior. Appetite 7(Suppl):115–126PubMedGoogle Scholar
  19. Fantino M, Boucher H, Faïon F, Mathiot P (1988) Dexfenfluramine and body weight regulation: experimental study with hoarding behavior. Clin Neuropharmacol 11(Suppl 1):S97–S104PubMedGoogle Scholar
  20. Ferrari F, Pelloni F, Giuliani D (1992) B-HT 920 stimulates feeding and antagonizes anorexia induced by ACTH and immobilisation. Eur J Pharmacol 210:17–22PubMedGoogle Scholar
  21. Fray PJ, Koob GF, Iversen SD (1982) Tail-pinch-elicited behavior in rats: preference, plasticity and learning. Behav Neural Biol 36:108–136PubMedGoogle Scholar
  22. Gaetani S, Oveisi F, Piomelli D (2003) Modulation of meal pattern in the rat by the anorectic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28:1311–1316PubMedGoogle Scholar
  23. Garattini S (1992) An update on the pharmacology of serotoninergic appetite-suppressive drugs. Int J Obesity 16(Suppl l4):S41–S48Google Scholar
  24. Garattini S, Bizzi A, Codegoni AM, Caccia S, Mennini T (1992a) Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr 55:160S–166SPubMedGoogle Scholar
  25. Garattini S, Bizzi A, Caccia S, Mennini T (1992b) Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Int J Obes 16(Suppl 3):S43–S50Google Scholar
  26. Gilbert F, Dourish CT (1987) Effects of the novel anxiolytics gespirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT. Psychopharmacology (Berl) 93:349–352Google Scholar
  27. Hammer VA, Gietzen DW, Beverly JL, Rogers QR (1990) Serotonin3 receptor antagonists block anorectic responses to amino acid imbalance. Am J Physiol Regul Integr Comp Physiol 259:R627–R636Google Scholar
  28. Herling AW, Kilp S, Juretschke HP, Neumann-Haefelin C, Gerl M, Kramer W (2008a) Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant. Int J Obes (Lond) 32:1363–72Google Scholar
  29. Herling AW, Kilp S, Elvert R, Haschke G, Kramer W (2008b) Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinology 149:2557–66PubMedGoogle Scholar
  30. Hull KM, Maher TJ (1990) L-Tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats. J Pharmacol Exp Ther 255:403–409PubMedGoogle Scholar
  31. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ (1997) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613–1618PubMedCentralPubMedGoogle Scholar
  32. Knoll J (1979) Satietin: a highly potent anorexogenic substance in human serum. Physiol Behav 23:497–502PubMedGoogle Scholar
  33. Knoll J (1984) Satietin: a 50000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity. J Neural Transm 59:163–194PubMedGoogle Scholar
  34. Leung PMB, Rogers QR (1969) Food intake: regulation by plasma amino acid pattern. Life Sci 8:1–9PubMedGoogle Scholar
  35. Maher TJ, Hull KM (1990) Effects of L-tyrosine on the anorectic activity of mixed-acting sympathomimetics in hyperphagic rats. Eur J Pharmacol 183:429–430Google Scholar
  36. Mennini T, Bizzi A, Caccia S, Codegoni A, Fracasso C, Frittoli E, Guiso G, Padura IM, Taddei C, Uslenghi A, Garattini S (1991) Comparative studies on the anorectic activity of d-fenfluramine in mice, rats and guinea pigs. Naunyn Schmiedeberg’s Arch Pharmacol 343:483–490Google Scholar
  37. Nagy J (1994) Purification of the anorectic agents satietin from bovine serum. Pharmacol Biochem Behav 48:17–22PubMedGoogle Scholar
  38. Nishida KJ, Dougherty GG, Ellinwood EH, Rockwell WJK (1990) Effects of chronic chlorimipramine and imipramine administration on food hoarding behavior in male rats. Res Commun Psychol Psychiatry Behav 15:115–128Google Scholar
  39. Robert JJ, Orosco M, Rouch C, Jacquot C, Cohen Y (1989) Unexpected responses of the obese “cafeteria” rat to the peptide FMRF-amide. Pharmacol Biochem Behav 34:341–344PubMedGoogle Scholar
  40. Rosofsky M, Geary N (1989) Phenylpropanolamine and amphetamine disrupt postprandial satiety in rats. Pharmacol Biochem Behav 34:797–803PubMedGoogle Scholar
  41. Rouru J, Huuponen R, Pesonen U, Koulu M (1992) Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci 50:1813–1820PubMedGoogle Scholar
  42. Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 308:159–163Google Scholar
  43. Simansky KJ, Vaidya AH (1990) Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res Bull 25:953–960PubMedGoogle Scholar
  44. Simmons RD, Blosser JC, Rosamond JR (1994) FPL 14294: a novel CCK-8 agonist with potent intranasal anorectic activity in the rat. Pharmacol Biochem Behav 47:701–708PubMedGoogle Scholar
  45. Stevens R, Edwards S (1996) Effect of a 5-HT3 antagonist on peripheral 5-hydroxytryptamine-induced anorexia. Psychobiology 24:67–70Google Scholar
  46. Thurlby PL, Samanin R (1981) Effects of anorectic drugs and prior feeding on food-rewarded runway behavior. Pharmacol Biochem Behav 14:799–804PubMedGoogle Scholar
  47. Vergoni AV, Poggioli R, Marrama D, Bertolini A (1990) Inhibition of feeding by ACTH-(1–24): behavioral and pharmacological aspects. Eur J Pharmacol 179:347–355PubMedGoogle Scholar
  48. Voigt JP, Fink H, Marsden CA (1995) Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 351:217–220Google Scholar

Computer-Assisted Measurement of Food Consumption in Mice and Rats

  1. Bickel M, Jaehne G, Stapf M, Wandschneider J, Gossel M (2000) Microstructural analysis of feeding behavior after amphetamine, sibutramine and dexfenfluramine in rats. Int J Obes 24(Suppl 1): Abstract 413Google Scholar
  2. Bickel M, Gossel M, Jaehne G (2002) Acute and chronic effects of the CCKA-receptor agonist (SR146131) on body weight development, feed consumption and the pancreas in rodents. In: Benedetti E, Pedone C (eds) Peptides 2002. Proceedings of the 27th European peptide symposium, 31 August to 6 September 2002, Sorrento, Italy. Edizioni Ziino, Naples, pp 436–437Google Scholar
  3. Bickel M, Gossel M, Jaehne G, Lang HJ, Sandow J (2003) Antiobesic effect of HMR1426 and obesity and diabetes related serum parameters in female Zucker fatty rats. Int J Obes 27(Suppl 1): Abstract T4:P4–012Google Scholar
  4. Bickel M, Gossel M, Geisen K, Jaehne J, Lang HJ, Rosenburg R, Sandow J (2004) Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats. Int J Obes 28:211–221Google Scholar
  5. Gossel M, Bickel M, Jaehne G, Stapf M, Wandschneider J, Sandow J (2001) Effect of 14 days treatment with HMR1426, a new anorectically acting drug, on body weight development and obesity related serum parameters in Zucker fatty rats. Obes Res Suppl 9: Abstract PG72Google Scholar
  6. Hansen HH, Hansen G, Paulsena S, Vrang N, Mark M, Jelsing J, Klein T (2014) The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat. Eur J Pharmacol 741:254–63PubMedGoogle Scholar

Indirect Calorimetry

  1. Boschmann M, Frenz U, Noack R, Aust L, Murphy CM (1994) Energy metabolism and metabolite patterns of rats after application of dexfenfluramine. Int J Obes Relat Metab Disord 18:235–242PubMedGoogle Scholar
  2. Butler AA, Kozak LP (2010) A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59:323–29PubMedCentralPubMedGoogle Scholar
  3. Cannon B, Nedergaard J (2011) Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol 214:242–53PubMedGoogle Scholar
  4. Cannon B, Nedergaard J (2014) The Browning of White Adipose Tissue: some burning issues. Cell Metab 20:396–407PubMedGoogle Scholar
  5. Ghorbani M, Claus TH, Himms-Hagen J (1997) Hypertrophy of brown adipocytes in brown and white adipose tissue and reversal of diet-induced obesity in rats treated with a β 3-adrenoceptor agonist. Biochem Pharmacol 54:121–131PubMedGoogle Scholar
  6. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37:287–301PubMedGoogle Scholar
  7. Herling AW, Kilp S, Elvert R, Haschke G, Kramer W (2008) Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinology 149:2557–2566Google Scholar
  8. Himms-Hagen J (1997) On raising energy expenditure in ob/ob mice. Science 276:1132–3PubMedGoogle Scholar
  9. Himms-Hagen J, Cui J, Danforth E Jr, Taatjes DJ, Lang SS, Waters BL, Claus TH (1994) Effect of CL-316,243, a thermogenic β 3-agonist, on energy balance and brown and white adipose tissue in rats. Am J Physiol 266(Regul Integr Comp Physiol 35):R1371–1382Google Scholar
  10. Jensen DR, Gayles EC, Ammon S, Phillips R, Eckel RH (2001) A self-correcting indirect calorimeter system for the measurement of energy balance in small animals. J Appl Physiol 90:912–918PubMedGoogle Scholar
  11. Molnar JA, Cunningham JJ, Miyatani S, Vizulis A, Write JD, Burke JF (1986) Closed-circuit metabolic system with multiple applications. J Appl Physiol 61:1582–1585PubMedGoogle Scholar
  12. Niemegeers CJE, Janssen PAJ (1979) Differential antagonism to amphetamine-induced oxygen consumption and agitation by psychoactive drugs. In: Fielding S, Lal H (eds) Industrial pharmacology. vol II, Antidepressants. Futura Publishing, New York, pp 125–141Google Scholar
  13. Paulik MA, Buckholz RG, Lancaster ME, Dallas WS, Hull-Ryde EA, Weiel JE, Lenhard JM (1998) Thermogenic effects of uncoupling protein-2, troglitazone, and β-adrenoceptor agonists. Pharm Res 15:944–949PubMedGoogle Scholar
  14. Poon TKY, Cameron DP (1978) Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity. Am J Physiol 234:E532–E534PubMedGoogle Scholar
  15. Rothwell NJ (1989) Central activation of thermogenesis by prostaglandins: dependence on CRF. Horm Metab Res 22:616–618Google Scholar
  16. Stock MJ (1975) An automatic close-circuit oxygen consumption apparatus for small animals. J Appl Physiol 253:1271–1276Google Scholar
  17. Tschoep MH, Speakman JR, Arch JR, Auwerx J, Bruening JC, Chan L, Eckel RH, Farese RV, Galgani JE, Hambly C et al (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9:57–63Google Scholar
  18. Yoshida T, Yoshioka K, Kamanaru K, Hiraoka N, Kondo M (1990) Mitigation of obesity by BRL 26830A, a new β-adrenoceptor agonist, in MSG obese mice. J Nutr Sci Vitaminol 36:75–80PubMedGoogle Scholar
  19. Yoshida T, Hiraoka N, Yoshioka K, Hasegawa G, Kondo M (1991) Anti-obesity and anti-diabetic actions of a β 3-adrenoceptor agonist, BRL 28630A, in yellow kk mice. Endocrinol Jpn 38:397–403Google Scholar

Bomb Calorimetry

  1. Elvert R, Wille A, Wandschneider J, Werner U, Glombik H, Herling AW (2012) Energy loss via urine and faeces – a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight. Diab Obes Metab 15:324–34Google Scholar

GDP-Binding in Brown Adipose Tissue

  1. Arch JRS, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163–165PubMedGoogle Scholar
  2. Foster DO (1986) Quantitative role of brown adipose tissue in thermogenesis. In: Trayhurn P, Nicholls DG (eds) Brown adipose tissue. Edward Arnold, London, pp 31–51Google Scholar
  3. Halloway BR (1989) Selective β-agonists of brown fat and thermogenesis. In: Lardy H, Stratman F (eds) Hormones, thermogenesis and obesity. Elsevier, New York, pp 477–484Google Scholar
  4. Himms-Hagen J (1989) Brown adipose tissue thermogenesis and obesity. Progr Lipid Res 28:67–115Google Scholar
  5. Isler D, Hill HP, Meier MK (1987) Glucose metabolism in isolated brown adipocytes under β-adrenergic stimulation. Quantitative contribution of glucose to total thermogenesis. Biochem J 245:789–793PubMedCentralPubMedGoogle Scholar
  6. Kajita J, Kobayashi S, Yoshida T (1994) Effect of benidipine hydrochloride on regional blood flow of the adipose tissue in anesthetized rats. Arzneim Forsch/Drug Res 44:297–300Google Scholar
  7. Milner RE, Wilson S, Arch JRS, Trayhurn A (1988) Acute effects of a β-adrenoceptor agonist (BRL 26830A) on rat brown adipose tissue mitochondria. Biochem J 249:759–763Google Scholar
  8. Nedergaaard J, Jacobsson A, Cannon B (1989) Adrenergic regulation of thermogenin activity and amount in brown adipose tissue. In: Lardy H, Stratman F (eds) Hormones, thermogenesis and obesity. Elsevier, New York, pp 105–116Google Scholar
  9. Nicholls DG (1976) Hamster-brown-adipose tissue mitochondria: purine nucleotide control of the ionic conductance of the inner membrane, the nature of the nucleotide binding site. Eur J Biochem 62:223–228PubMedGoogle Scholar
  10. Nicholls DG, Cunningham SA, Rial E (1986) The bioenergetic mechanisms of brown adipose tissue thermogenesis. In: Trayhurn P, Nicholls DG (eds) Brown adipose tissue. Edward Arnold, London, pp 52–85Google Scholar
  11. Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is generally more applicable. Anal Biochem 83:346–356PubMedGoogle Scholar
  12. Ricquier D, Mory G (1984) Factors affecting brown adipose tissue in animals and man. Clin Endocrinol Metab 13:501–521PubMedGoogle Scholar
  13. Ricquier D, Bouillaud F (1986) The brown adipose tissue mitochondrial uncoupling protein. In: Trayhurn P, Nicholls DG (eds) Brown adipose tissue. Edward Arnold, London, pp 86–104Google Scholar
  14. Santti E, Huupponen R, Rouro J, Hänninen V, Pesonen U, Jhanwar-Uniyal M, Koulu M (1994) Potentiation of the anti-obesity effect of the β 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise. Br J Pharmacol 113:1231–1236PubMedCentralPubMedGoogle Scholar
  15. Savontaus E, Raasmaja A, Rouru J, Koulu M, Pesonen U, Virtanen R, Savola JM, Huupponen R (1997) Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity. Eur J Pharmacol 328:207–215PubMedGoogle Scholar
  16. Swick RW, Henningfield MF (1989) Changes in the number of GDP binding sites on brown adipose tissue (BAT) mitochondria and its uncoupling protein. In: Lardy H, Stratman F (eds) Hormones, thermogenesis and obesity. Elsevier, New York, pp 117–127Google Scholar
  17. Takahashi H, Nakano K, Yasuda TT, Komiyma Y, Muakami T, Nishimura M, Nakanishi T, Sakamoto SH, Nanbu A, Yoshimura M (1994) Anti-obesity and anti-diabetic effects of carterenol in non-insulin dependent diabetic mice. Clin Exp Pharmacol Physiol 21:477–483PubMedGoogle Scholar
  18. Yoshida T, Nishioka H, Nakamura Y, Kondo M (1984) Reduced norepinephrine turnover in mice with monosodium glutamate-induced obesity. Metabolism 33:1060–1063PubMedGoogle Scholar
  19. Yoshida T, Nishioka H, Nakamura Y, Kanatsuna T, Kondo M (1985) Reduced norepinephrine turnover in brown adipose tissue of pre-obese mice treated with monosodium-L-glutamate. Life Sci 36:931–938PubMedGoogle Scholar
  20. Yoshida T, Hiraoka N, Yoshioka K, Hasegawa G, Kondo M (1991) Anti-obesity and anti-diabetic actions of a β 3-adrenoceptor agonist, BRL 28630A, in yellow kk mice. Endocrinol Jpn 38:397–403Google Scholar
  21. Yoshida T, Sakane N, Wakabayashi Y, Umekawa T, Kondo M (1994a) Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific β 3-adrenoceptor agonist, in yellow KK mice. Life Sci 54:491–498PubMedGoogle Scholar
  22. Yoshida T, Umekawa T, Wakabayashi Y, Sakane N, Kondo M (1994b) Mechanism of anti-obesity action of benidipine hydrochloride in mice. Int J Obes 18:776–779Google Scholar
  23. Yoshida T, Umekawa T, Wakabayashi Y, Yoshimoto K, Sakane N, Kondo M (1996) Anti-obesity and anti-diabetic effects of mazindol in yellow kk mice: its activating effect on brown adipose tissue thermogenesis. Clin Exp Pharmacol Physiol 23:476–482PubMedGoogle Scholar
  24. Umekawa T, Yoshida T, Sakane N, Saito M, Kumamoto K (1997) Anti-obesity and anti-diabetic effects of CL316,243, a highly specific β 3-adrenoceptor agonist, in Otsuka Long Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur J Endocrinol 136:429–437Google Scholar

Uncoupling Protein and GLUT4 in Brown Adipose Tissue

  1. Bartness TJ, Billington CJ, Levine AS, Morley JE, Brown DM, Rowland ME (1986) Insulin and metabolic efficacy in rats. I. Effects of sucrose feeding and BAT axotomy. Am J Physiol 251:R1108–R1117Google Scholar
  2. Berraondo B, Matrti A, Duncan JS, Trayhurn P, Martinez JA (2000) Up-regulation of muscle UPC2 gene expression by a new β 3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals. Int J Obes 24:156–163Google Scholar
  3. Boss O, Samec S, Paolini-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP (1997) Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39–42PubMedGoogle Scholar
  4. Branco M, Ribeiro M, Negrao N, Bianco C (1999) 3,5,3′-Triiodothyronine actively stimulates UCP in brown fat under minimal sympathetic activity. Am J Physiol 276; Endocrinol Metab 39:E179–E187Google Scholar
  5. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269–272PubMedGoogle Scholar
  6. Foellmi-Adams LA, Wyss BM, Herron D, Nedergaard J, Kletzien RF (1996) Induction of uncoupling protein in brown adipose tissue. Synergy between norepinephrine and pioglitazone, an insulin-sensitizing agent. Biochem Pharmacol 52:693–701PubMedGoogle Scholar
  7. Ghorbani M, Himms-Hagen J (1997) Appearance of brown adipocytes in white adipose tissue during CL316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord 21:465–475PubMedGoogle Scholar
  8. Gong DW, He Y, Karas M, Reitman M (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β 3-adrenergic agonists, and leptin. J Biol Chem 272:24129–24132PubMedGoogle Scholar
  9. Kotz CM, Wang CF, Briggs JE, Levine AS, Billington CJ (2000) Effect of NPY in the hypothalamic paraventricular nucleus on uncoupling protein 1, 2, and 3 in the rat. Am J Physiol 278; Regul Integr Comp Physiol 47:R494–R498Google Scholar
  10. Lanni A, Beneduce L, Lombardi A, Moreno M, Boss O, Muzzin P, Giacobino JP, Goglia F (1999) Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett 444:250–254PubMedGoogle Scholar
  11. Larkin S, Mull E, Miao W, Pittner R, Albrandt K, Moore C, Young A, Denaro M, Beaumont K (1997) Regulation of the third member of the uncoupling protein family, UCP3, by cold and thyroid hormone. Biochem Biophys Res Commun 240:222–227PubMedGoogle Scholar
  12. Lin CS, Klingenberg M (1980) Isolation of the uncoupling protein from brown adipose tissue mitochondria. FEBS Lett 133:299–303Google Scholar
  13. Liu YL, Stock MJ (1995) Acute effects of the β 3-adrenocptor agonist, BRL 35135, on tissue glucose utilization. Br J Pharmacol 114:888–894PubMedCentralPubMedGoogle Scholar
  14. Liu YL, Kashani SMZ, Heal DJ, Stock MJ (1996) Effect of sibutramine on tissue glucose utilization in the rat. Br J Pharmacol 117:324PGoogle Scholar
  15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  16. Mao W, Yu XX, Zhong A, Li W, Brush J, Sherwood SW, Adams SA, Pan G (1999) UCP, a novel, brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett 443:326–330PubMedGoogle Scholar
  17. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurakawa M, Sataka T (1997) Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Lett 418:323–326PubMedGoogle Scholar
  18. Matsuda J, Hosada K, Itoh H, Son C, Doi K, Tanaka T, Fukunaga Y, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K (1997) Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed a high fat diet. FEBS Lett 418:200–204PubMedGoogle Scholar
  19. Milner RE, Wilson S, Arch JRS, Trayhurn P (1988) Acute effects of a β-adrenoceptor agonist (BRL 26830A) on rat brown-adipose-tissue mitochondria. Biochem J 249:759–763Google Scholar
  20. Nagase I, Yoshida T, Kumamoto K, Umekawa T, Sakane N, Nikami H, Kawada T, Saito M (1996) Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic β 3-adrenergic agonist. J Clin Invest 97:2898–2094PubMedCentralPubMedGoogle Scholar
  21. Paulik MA, Lenhard M (1997) Thiazolidinediones inhibit alkaline phosphatase activity while increasing expression off uncoupling protein, deiodinase, and increasing mitochondrial mass in C3H10T1/2 cells. Cell Tissue Res 290:79–87PubMedGoogle Scholar
  22. Puigserver P, Vazquez F, Bonet ML, Pico C, Palou A (1996) In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. Biochem J 317:827–833PubMedCentralPubMedGoogle Scholar
  23. Ricquier D, Raimbault S, Champigny O, Miroux B, Bouillaud F (1992) The uncoupling protein is not expressed in rat liver. FEBS Lett 303:103–106PubMedGoogle Scholar
  24. Savontaus E, Rouro J, Boss O, Huupponen R, Koulu M (1998) Differential regulation of uncoupling proteins by chronic treatments with β 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats. Biochem Biophys Res Commun 246:899–904PubMedGoogle Scholar
  25. Scarpace PJ, Matheney M (1996) Thermogenesis in brown adipose tissue with age: post-receptor activation by forskolin. Eur J Physiol 431:388–394Google Scholar
  26. Scarpace PJ, Matheny M, Moore RL, Kumar MV (2000) Modulation of uncoupling protein 2 and uncoupling protein 3: regulation by denervation, leptin and retinoic acid treatment. J Endocrinol 164:331–337PubMedGoogle Scholar
  27. Shimabukuro M, Zhou YT, Unger RH (1997) Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats. Biochem Biophys Res Commun 237:359–361PubMedGoogle Scholar
  28. Shimizu Y, Nikami H, Tsukazaki K, Machado UF, Yano H, Seino Y, Saito M (1993) Increased expression of glucose transporter GLUT-4 in brown adipose tissue of fasted rats after cold exposure. Am J Physiol 264:E890–E895PubMedGoogle Scholar
  29. Shrago E, McTigue J, Katiyar S, Woldegiorgis C (1989) Preparation of highly purified reconstituted uncoupling protein to study biochemical mechanism(s) of proton conductance. In: Lardy H, Stratman F (eds) Hormones, thermogenesis and obesity. Elsevier, New York, pp 129–136Google Scholar
  30. Stock MJ (1997) Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int J Obes Relat Metab Disord 21(Suppl 1):S25–S29PubMedGoogle Scholar
  31. Tonello C, Dioni L, Briscini L, Nisoli E, Carruba MO (1998) SR59230A blocks β 3-adrenoreceptor-linked modulation of uncoupling protein-1 and leptin in rat brown adipocytes. Eur J Pharmacol 352:125–129PubMedGoogle Scholar
  32. Umekawa T, Yoshida T, Sakane N, Saito M, Kumamoto K, Kondo M (1997) Anti-obesity and anti-diabetic effects of CL316,243, a highly specific β 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima fatty rats: induction of uncoupling protein and activation of GLUT4 in white fat. Eur J Endocrinol 136:429–437Google Scholar
  33. Viadal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB (1997) UCP3: An uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 235:79–82Google Scholar
  34. Yonetani T, Ray GS (1965) A study on cytochrome oxidase: kinetics of the aerobic oxidation of ferrocytochrome c by cytochrome oxidase. J Biol Chem 240:3392–3398PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Sanofi-Aventis Deutschland GmbHFrankfurtGermany

Personalised recommendations